NCT02920021Phase 2Completed

Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy

Study sponsor: AnaptysBio, Inc. · ANAB

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2018-03-30Actual
Enrollment · participants20Actual
Source updated2023-07-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.